Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Highlights For Emphasis - Dear Fellow Shareholders,
Here's a snippet of the letter to shareholders. Highlighted for emphasis are the points verified and discussed at length in a phone conversation with the CEO. Nothing new, just verification of what he's already put out there, but enough for me to accumulate another 10M shares yesterday and this morning based strictly off that conversation. GLTA and I hope like hell for each of your sakes that you don't sell even one share of this very unique and amazing opportunity. UF
"I’m sure you’re all wondering about the new management, additions to our Board of Directors and our business model moving forward. I will say that I am excited to begin executing our model, although we started the process about a year ago, we decided on using CWIR as our public platform a few months ago. We also had to make sure our partners were on board and our deal flow pipeline was strong.
A question that has been asked is, why start on the Pinks? There are a few reasons, NYSE and Nasdaq companies for the taking just don’t exist and if they do, the acquisition cost is probably close to around $100 million. Starting from scratch with an S-1, fund raising, FINRA, IPO process is time consuming and our story would have been lost in paperwork drafts and amendments. Going with the OTC market puts us on a “fast track” and we are using this platform only as a stepping stone to building our shareholder base, our financials, making sure our in-house compliance department is in order so when we decide to up-list, we’ll be ahead of the curve.
With the pipeline of companies (plural) we have signed to Letters of Intent to purchase, we would meet the listing criteria with our initial acquisition. Are we going to apply right away? Probably not, I’d like to build our consolidated financials first. We’d like to have some real size and depth before considering.
So what exactly is our business model? We’re an acquisition holding company that will purchase private operating businesses (plural) with annual revenues of between $5 million to around $30 million. These businesses will become wholly owned subsidiaries of CWIR, the parent company.
I do believe this may be the first time that a microcap pink sheet listed company purchased a business many times its current market cap. We look for management teams that want to work together with us, as a team, to grow and expand the business. They will be able to focus on executing the business while we focus on investments, capital markets, investor relations and regulations.
At some point in the future, be it two or three years, depending on the market environment, we’ll consider spinning subsidiary off. As a current shareholder during that time, you will also receive shares in that entity.
If you ask me where we see ourselves in five years, I would say that we would like to have ten to fifteen subsidiaries under our
umbrella at all times and spinning off or selling four or five each year.
I don’t roll the dice, I don’t gamble, I don’t hope things happen. I like to believe that I do sure things. As a matter of fact, I’ve only been to Vegas a handful of times because of these reasons. The way we do that is by controlling the process, structuring deals that make economic sense because we are executing on our terms.
What’s our industry focus? Quite frankly, we’re generalist, except for David Platt, who specializes in Pharma and Bio tech, and Ray that specializes in the financial arena, but at the end of the day we’re all deal guys."
CWIR BUY ALERT!!
so great at each level..whether a red day..or pullback on green days..the bid gets pelted with millions of shares that some probably bought in the .000's ..however the bid holds strong each time.. this stock has been looking incredibly strong.. if they have the goods..see ya somewhere above .01 very soon..maybe .05? ...Maybe they bring something else into this ticker soon?
imho
mj
Many are still loading for multi pennies CWIR, the board will be buzzing soon enough, whales are quiet while loading
Tune in Sunday 6pm PST: on KSCO radio. I’ll be mentioning my buy in on this company along with interviewing CEO of Amfil Technologies.
Ksco.com
What did he say?!
Added a few this morning at the HOD but feel good about it after reviewing the recent DD. Sure looks good besides those I bought back in June at .0004.
Spoke with the CEO yesterday...OMG!!!
CWIR board/director David Platt OXYGEN THERAPY board members.....stunning LEGIT....
http://www.otipharma.com/wp-content/uploads/2017/03/OT-short-presentation-03-16-2017-V-2.0.pdf
David Platt, Ph.D.
CEO/Chairman of the Board
Dr. Platt is a world-renowned
expert in carbohydrate chemistry
and has founded three publiclytraded
companies, creating nearly
$1B for investors. Prior to Boston
Therapeutics, (OTC: BTHE) from
2001 to 2009, Dr. Platt was a
founder, Chief Executive Officer
and Chairman of the Board at ProPharmaceuticals,
Inc. (OTC:PRWP
and AMEX: PRW, NASDAQ: GALT).
From 1995 to 2000 Dr. Platt was
the founder of International Gene
Group (NASDAQ: IGGI, GLGS)
Yuval Kwintner
B.S., MBA, LL.B
President & Board Member
An experienced entrepreneur and
business executive with proven
abilities in both established
organizations and start-up
ventures. Earned an MBA from
MIT Sloan School of Management,
a B.Sc. from the Technion - Israel
Institute of Technology, and an
LL.B. (JD equivalent) from Tel Aviv
University
Dr. Ben-Zion Weiner, PhD
SCIENTIFIC ADVISORY BOARD CHAIRMAN
Dr. Ben-Zion Weiner was Head of Global
Research and Development at Teva
Pharmaceutical Industries Ltd. for over three
decades, including as a member of the Teva
Executive Committee. He directly oversaw all
pharmaceutical development and regulatory
approval of Teva’s innovative product pipeline.
Dr. Weiner was also responsible for the
development of hundreds of generic products
for the US, European, and other markets. He
received a BSc degree in general chemistry
and biochemistry and an MSc degree in
organic chemistry, graduating with distinction
for both degrees from the Hebrew University,
Jerusalem. He received his PhD degree in
chemistry at the Hebrew University,
Jerusalem, and conducted his post-doctoral
research at Schering-Plough Corporation in
the United States.
Hana Chen-Walden, M.D.
Medical Advisory Board Chairman
Dr. Chen-Walden is an Endocrinologist and
has specialized in regulatory affairs in the
pharmaceutical industry in the U.S and
Europe. Dr. Chen-Walden has more than
35 years of regulatory experience with the
EMEA and in individual European Dr. Chen
Walden received her Doctorate of
Medicine from University of Tel Aviv, Israel.
Dr. Chen-Walden has practiced medicine in
Germany and France
Benjamin Rivnay, Ph.D.
Chief Scientist Director of R&D at Formatech
Managed 50+ projects on formulation
development Vice President, R&D and Lab
Director at Repromedix: Introduced over 50
new test products Senior Investigator and
Program Leader at Procept: Initiated and led
R&D programs Senior Scientist at Neurex
Corporation Associate Professor of
Biochemistry Ph.D., Biochemistry,
Weizmann Institute of Science; B.Sc.,
Biology, Tel Aviv University
Ache Stokelman, B.S.
Senior Advisor
Ache is a veteran of the Biotech industry. He
spent over 20 years at Amgen where he
invented, developed and deployed new
technologies and methods for Process
Development. Earlier in his career he
designed, build and troubleshoot safety and
control systems on offshore platforms. He
obtained a BS in Mechanical Engineering at
The Technion Institute of Technology, Israel
New Facebook stock group for $CWIR
https://www.facebook.com/groups/136180383678073/
DD is in place more than 2 pennies EOY then I’ll be up 35 grand
Got in with small position today.
Thanks, great DD here
Added that dip this morning after discovering this just last night.
NHoD coming here !
Yes brother love the DD here $CWIR
Heavy volume to start the day, looks like more and more people are seeing how undervalued this is!
Nice bro. Really like this one. Valuations on this are going to be sick upon deal closing. 10m+ in assets, chapter 11 eliminating liabilities, and we have 28.8m in revs for 2016.
Assets higher than market cap. lol
Wish i held my millions too!!!! Im thinking about getting back in right now before penny break. GL CWIR
So much for people waiting for the dip.
over 005 looks like its ready to continue
0.005 broke next attack 0.007
Nice continuation here today, still holding.
did u say by 10?
This is OWC$ all over again.
And away we go!! Shares are very tight
It very hard to predict PPS movement because this is not your average penny otc stock. Watch .005 by noon.IMO
larger bids filing in..will just take one to get an itchy trigger finger and we see .0045 in a blink..lol
imho
mj
Got my entry level position .0037! Let's go!
Followers
|
426
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
54143
|
Created
|
05/19/03
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |